Chromosome 21-derived hsa-miR-155-5p regulates mitochondrial biogenesis by targeting Mitochondrial Transcription Factor A (TFAM)

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1852, Issue 7, 2015, Pages 1420-1427

  Quiñones Lombraña, Adolfo ^a   Blanco, Javier G ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

Down syndrome; Hsa miR 155 5p; Mitochondrial biogenesis; TFAM

Indexed keywords

MICRORNA 155; MITOCHONDRIAL DNA; MITOCHONDRIAL TRANSCRIPTION FACTOR A; DNA BINDING PROTEIN; MICRORNA; MIRN155 MICRORNA, HUMAN; MITOCHONDRIAL PROTEIN; TFAM PROTEIN, HUMAN; TRANSCRIPTION FACTOR;

ANIMAL CELL; ARTICLE; BIOGENESIS; CELL VIABILITY; CHROMOSOME 21; CONTROLLED STUDY; DNA CONTENT; DOWN REGULATION; DOWN SYNDROME; FIBROBLAST; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MITOCHONDRION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; ANIMAL; CASE CONTROL STUDY; CELL CULTURE; CHO CELL LINE; CRICETULUS; GENETICS; HAMSTER; HEART MUSCLE CELL; METABOLISM; MITOCHONDRIAL DYNAMICS; PLOIDY;

ANIMALS; CASE-CONTROL STUDIES; CELLS, CULTURED; CHO CELLS; CHROMOSOMES, HUMAN, PAIR 21; CRICETINAE; CRICETULUS; DNA, MITOCHONDRIAL; DNA-BINDING PROTEINS; DOWN SYNDROME; FIBROBLASTS; HUMANS; MICRORNAS; MITOCHONDRIAL PROTEINS; MITOCHONDRIAL TURNOVER; MYOCYTES, CARDIAC; PLOIDIES; TRANSCRIPTION FACTORS;

EID: 84927933336     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2015.04.004     Document Type: Article

References (32)

1. Falkenberg M., Larsson N.G., Gustafsson C.M. DNA replication and transcription in mammalian mitochondria. Annu. Rev. Biochem. 2007, 76:679-699.
2. Gensler S., Weber K., Schmitt W.E., Perez-Martos A., Enriquez J.A., Montoya J., Wiesner R.J. Mechanism of mammalian mitochondrial DNA replication: import of mitochondrial transcription factor A into isolated mitochondria stimulates 7S DNA synthesis. Nucleic Acids Res. 2001, 29:3657-3663.
3. Matsushima Y., Goto Y., Kaguni L.S. Mitochondrial Lon protease regulates mitochondrial DNA copy number and transcription by selective degradation of mitochondrial transcription factor A (TFAM). Proc. Natl. Acad. Sci. U. S. A. 2010, 107:18410-18415.
4. Pohjoismaki J.L., Wanrooij S., Hyvarinen A.K., Goffart S., Holt I.J., Spelbrink J.N., Jacobs H.T. Alterations to the expression level of mitochondrial transcription factor A, TFAM, modify the mode of mitochondrial DNA replication in cultured human cells. Nucleic Acids Res. 2006, 34:5815-5828.
5. Ekstrand M.I., Falkenberg M., Rantanen A., Park C.B., Gaspari M., Hultenby K., Rustin P., Gustafsson C.M., Larsson N.G. Mitochondrial transcription factor A regulates mtDNA copy number in mammals. Hum. Mol. Genet. 2004, 13:935-944.
6. Filipowicz W., Bhattacharyya S.N., Sonenberg N. Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nature reviews. Genetics 2008, 9:102-114.
7. Jiang J.D., Yang J.F., Wang Z.F., Wu G.Y., Liu F. TFAM is directly regulated by miR-23b in glioma. Oncol. Rep. 2013, 30:2105-2110.
8. Yamamoto H., Morino K., Nishio Y., Ugi S., Yoshizaki T., Kashiwagi A., Maegawa H. MicroRNA-494 regulates mitochondrial biogenesis in skeletal muscle through mitochondrial transcription factor A and Forkhead box j3. Am. J. Physiol. Endocrinol. Metab. 2012, 303:E1419-E1427.
9. Yao J., Zhou E., Wang Y., Xu F., Zhang D., Zhong D. microRNA-200a inhibits cell proliferation by targeting mitochondrial transcription factor A in breast cancer. DNA Cell Biol. 2014, 33:291-300.
10. Faraoni I., Antonetti F.R., Cardone J., Bonmassar E. miR-155 gene: a typical multifunctional microRNA. (BBA) - Mol. Basis Dis. 2009, 1792:497-505.
11. O'Connell R.M., Taganov K.D., Boldin M.P., Cheng G.H., Baltimore D. MicroRNA-155 is induced during the macrophage inflammatory response. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:1604-1609.
12. Corsten M.F., Papageorgiou A., Verhesen W., Carai P., Lindow M., Obad S., Summer G., Coort S.L.M., Hazebroek M., van Leeuwen R., Gijbels M.J.J., Wijnands E., Biessen E.A.L., De Winther M.P.J., Stassen F.R.M., Carmeliet P., Kauppinen S., Schroen B., Heymans S. MicroRNA profiling identifies microRNA-155 as an adverse mediator of cardiac injury and dysfunction during acute viral myocarditis. Circ Res 2012, 111:415. (U155).
13. Sethupathy P., Borel C., Gagnebin M., Grant G.R., Deutsch S., Elton T.S., Hatzigeorgiou A.G., Antonarakis S.E. Human microRNA-155 on chromosome 21 differentially interacts with its polymorphic target in the AGTR1 3' untranslated region: a mechanism for functional single-nucleotide polymorphisms related to phenotypes. Am. J. Hum. Genet. 2007, 81:405-413.
14. Hefti E., Quinones-Lombrana A., Redzematovic A., Hui J., Blanco J.G. Analysis of mtDNA, miR-155 and BACH1 expression in hearts from donors with and without Down syndrome. Mitochondrial DNA 2014, 1-8.
15. Letourneau A., Santoni F.A., Bonilla X., Sailani M.R., Gonzalez D., Kind J., Chevalier C., Thurman R., Sandstrom R.S., Hibaoui Y., Garieri M., Popadin K., Falconnet E., Gagnebin M., Gehrig C., Vannier A., Guipponi M., Farinelli L., Robyr D., Migliavacca E., Borel C., Deutsch S., Feki A., Stamatoyannopoulos J.A., Herault Y., van Steensel B., Guigo R., Antonarakis S.E. Domains of genome-wide gene expression dysregulation in Down's syndrome. Nature 2014, 508:345-350.
16. Valenti D., de Bari L., De Filippis B., Henrion-Caude A., Vacca R.A. Mitochondrial dysfunction as a central actor in intellectual disability-related diseases: an overview of Down syndrome, autism, Fragile X and Rett syndrome. Neurosci. Biobehav. Rev. 2014, 46:202-217.
17. Coskun P.E., Wyrembak J., Derbereva O., Melkonian G., Doran E., Lott I.T., Head E., Cotman C.W., Wallace D.C. Systemic mitochondrial dysfunction and the etiology of Alzheimer's disease and down syndrome dementia. J. Alzheimers Dis. 2010, 20(Suppl. 2):S293-S310.
18. Ogawa O., Perry G., Smith M.A. The "Down's" side of mitochondria. Dev. Cell 2002, 2:255-256.
19. Roat E., Prada N., Ferraresi R., Giovenzana C., Nasi M., Troiano L., Pinti M., Nemes E., Lugli E., Biagioni O., Mariotti M., Ciacci L., Consolo U., Balli F., Cossarizza A. Mitochondrial alterations and tendency to apoptosis in peripheral blood cells from children with Down syndrome. FEBS Lett. 2007, 581:521-525.
20. Arbuzova S., Hutchin T., Cuckle H. Mitochondrial dysfunction and Down's syndrome. Bioessays 2002, 24:681-684.
21. Infantino V., Castegna A., Iacobazzi F., Spera I., Scala I., Andria G., Iacobazzi V. Impairment of methyl cycle affects mitochondrial methyl availability and glutathione level in Down's syndrome. Mol. Genet. Metab. 2011, 102:378-382.
22. Coskun P.E., Busciglio J. Oxidative stress and mitochondrial dysfunction in Down's syndrome: relevance to aging and dementia. Current Gerontology and Geriatrics Research 2012, 2012:7.
23. Pallardo F.V., Lloret A., Lebel M., d'Ischia M., Cogger V.C., Le Couteur D.G., Gadaleta M.N., Castello G., Pagano G. Mitochondrial dysfunction in some oxidative stress-related genetic diseases: Ataxia-Telangiectasia, Down Syndrome, Fanconi Anaemia and Werner Syndrome. Biogerontology 2010, 11:401-419.
24. Mitra K., Lippincott-Schwart J. Analysis of mitochondrial dynamics and functions using imaging approaches. Current protocols in Cell Biology 2010, (Chapter 4), (Unit 4 25 21-21.). J.S. Bonifacino (Ed.).
25. Kalabus J.L., Sanborn C.C., Jamil R.G., Cheng Q.Y., Blanco J.G. Expression of the anthracycline-metabolizing enzyme carbonyl reductase 1 in hearts from donors with Down syndrome. Drug Metab. Dispos. 2010, 38:2096-2099.
26. Quinones-Lombrana A., Ferguson D., Hageman Blair R., Kalabus J.L., Redzematovic A., Blanco J.G. Interindividual variability in the cardiac expression of anthracycline reductases in donors with and without Down syndrome. Pharm. Res. 2014, 31(7):1644-1655.
27. Bustin S.A., Benes V., Garson J.A., Hellemans J., Huggett J., Kubista M., Mueller R., Nolan T., Pfaffl M.W., Shipley G.L., Vandesompele J., Wittwer C.T. The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin. Chem. 2009, 55:611-622.
28. Schmittgen T.D., Livak K.J. Analyzing real-time PCR data by the comparative C(T) method. Nat. Protoc. 2008, 3:1101-1108.
29. Rehmsmeier M., Steffen P., Hochsmann M., Giegerich R. Fast and effective prediction of microRNA/target duplexes. RNA 2004, 10:1507-1517.
30. Loeb G.B., Khan A.A., Canner D., Hiatt J.B., Shendure J., Darnell R.B., Leslie C.S., Rudensky A.Y. Transcriptome-wide miR-155 binding map reveals widespread noncanonical microRNA targeting. Mol. Cell 2012, 48:760-770.
31. Chen Y., Siegel F., Kipschull S., Haas B., Frohlich H., Meister G., Pfeifer A. miR-155 regulates differentiation of brown and beige adipocytes via a bistable circuit. Nat. Commun. 1769, 4(2013).
32. Piccoli C., Izzo A., Scrima R., Bonfiglio F., Manco R., Negri R., Quarato G., Cela O., Ripoli M., Prisco M., Gentile F., Cali G., Pinton P., Conti A., Nitsch L., Capitanio N. Chronic pro-oxidative state and mitochondrial dysfunctions are more pronounced in fibroblasts from Down syndrome foeti with congenital heart defects. Hum. Mol. Genet. 2013, 22:1218-1232.